Log in to your Inderes Free account to see all free content on this page.
ProstaLund
9.98
SEK
+5.27 %
PLUN
First North Stockholm
Medical Equipment & Services
Health Care
Less than 1K followers
+5.27%
+32.36%
+6.17%
-18.73%
-52.2%
-84.27%
-93.82%
-91.09%
-97.26%
ProstaLund operates in medical technology. Today, specialisation is mainly in the area of treatment of benign prostate enlargement (BPH). Through the company CoreTherm, heat treatment of benign prostate enlargement is offered, without the need for surgical operation. The vision is to offer both faster and more efficient solutions against traditional forms of infestation. The company was founded in 1991 and is operating globally, based in Lund.
Read moreMarket cap
36.17M SEK
Turnover
5.72K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
20.2.
2025
Annual report '24
16.5.
2025
Interim report Q1'25
27.5.
2025
General meeting '25
ShowingAll content types
The first ten CoreTherm® Eagle machines are manufactured
Interim report January-September 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio